Will patient-centric sampling become the norm for clinical trials after COVID-19?

作者：Christopher James, Matthew Barfield, Katie F. Maass, Shefali Patel, Melanie Anderson · 发表于：Nature Medicine · 年份：2020 · DOI：10.1038/s41591-020-01144-1 · 被引用次数：42 · 研究领域：Biosimilars and Bioanalytical Methods、Health Systems, Economic Evaluations, Quality of Life、Statistical Methods in Clinical Trials